We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tes... read more Featured Products: More products

Download Mobile App




Fully-Automated Calprotectin Immunoassay Validated for IBD Patients

By LabMedica International staff writers
Posted on 13 Jul 2020
The incidence of inflammatory bowel disease (IBD) is increasing. More...
This chronic intestinal inflammation disorder comprises two major forms of inflammation: Crohn’s disease (CD) and ulcerative colitis (UC). Distinction between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) based on clinical symptoms is often difficult.

Multiple studies have proven the use of calprotectin in IBD patients as a biomarker in monitoring disease activity, response to treatment and relapse. Calprotectin levels directly correlate with the amount of granulocytes present at the intestinal inflammation site, correlating with the severity of IBD. The amount of patients being screened with calprotectin for IBD is increasing to avoid unnecessary endoscopy, thus a need for an easy to use and quick laboratory assay arises.

Clinical Biochemists and their associates at the OLVG Oost Hospital (Amsterdam, the Netherlands) measured calprotectin in 303 subjects in five patient groups: IBD: ulcerative colitis (UC) and Crohn’s disease (CD); non-IBD: IBS, other gastrointestinal diseases and controls (healthy patients with no gastrointestinal disease). The patients provided fecal samples collected at home using a standard sample container provided by the laboratory. The samples were stored frozen up to one week before measuring calprotectin concentrations.

The Calprotectin Stool Extraction Device was used to prepare the stools for the Liaison calprotectin immunoassay and the fecal calprotectin immunoassay was conducted in the LIAISON XL analyzer (DiaSorin, Saluggia, Italy). This immunoassay was compared to the EliA calprotectin 2 immunoassay run on the Phadia ImmunoCAP250 (Thermo Fisher Scientific, Waltham, MA, USA).

The scientists reported that the calprotectin immunoassay of DiaSorin showed good analytical performance with frozen samples. The presence of blood in the stool can interfere with the measurement of calprotectin. Patients suffering from IBD (UC or CD) showed significant higher concentrations of fecal calprotectin compared to controls (UC:710 ± 921 mg/kg; CD:967 ± 1,243 mg/kg; controls:11 ± 8 mg/kg) using DiaSorin’s immunoassay. The remaining non-IBD groups showed no significant difference compared to controls. Follow-up of nine patients showed a significant decrease in fecal calprotectin after treatment. At 50 mg/kg cut-off value, the negative predictive value for DiaSorin’s immunoassay was 96% and the positive predictive value 83% (sensitivity of 95% and specificity of 86%).

The authors concluded that the lack of standardization contributes to the numerical differences between the two methods, but the qualitative conclusions do not differ. DiaSorin’s calprotectin immunoassay can be used both to distinguish between IBD and non-IBD patients as well as for follow-up of IBD patients. The assay has a shorter extraction time and the time of measuring is much shorter making it very suitable for laboratories with high throughput of samples. The study was published online on June 24, 2020 in the journal Practical Laboratory Medicine.


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.